Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus

Khurana, S and Verma, S and Verma, N and Crevar, CJ and Carter, DM and Manischewitz, J and King, LR and Ross, TM and Golding, H (2010) Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus. PLoS ONE, 5 (7).

Published Version
Available under License : See the attached license file.

Download (945kB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)


Background: In the face of impending influenza pandemic, a rapid vaccine production and mass vaccination is the most effective approach to prevent the large scale mortality and morbidity that was associated with the 1918 "Spanish Flu". The traditional process of influenza vaccine production in eggs is time consuming and may not meet the demands of rapid global vaccination required to curtail influenza pandemic. Methodology/Principal Findings: Recombinant technology can be used to express the hemagglutinin (HA) of the emerging new influenza strain in a variety of systems including mammalian, insect, and bacterial cells. In this study, two forms of HA proteins derived from the currently circulating novel H1N1 A/California/07/2009 virus, HA1 (1-330) and HA (1- 480), were expressed and purified from E. coli under controlled redox refolding conditions that favoured proper protein folding. However, only the recombinant HA1 (1-330) protein formed oligomers, including functional trimers that bound receptor and caused agglutination of human red blood cells. These proteins were used to vaccinate ferrets prior to challenge with the A/California/07/2009 virus. Both proteins induced neutralizing antibodies, and reduced viral loads in nasal washes. However, the HA1 (1-330) protein that had higher content of multimeric forms provided better protection from fever and weight loss at a lower vaccine dose compared with HA (1-480). Protein yield for the HA1 (1-330) ranged around 40 mg/Liter, while the HA (1-480) yield was 0.4-0.8 mg/Liter. Conclusions/Significance: This is the first study that describes production in bacterial system of properly folded functional globular HA1 domain trimers, lacking the HA2 transmembrane protein, that elicit potent neutralizing antibody responses following vaccination and protect ferrets from in vivo challenge. The combination of bacterial expression system with established quality control methods could provide a mechanism for rapid large scale production of influenza vaccines in the face of influenza pandemic threat.


Social Networking:
Share |


Item Type: Article
Status: Published
CreatorsEmailPitt UsernameORCID
Khurana, S
Verma, S
Verma, N
Crevar, CJ
Carter, DM
Manischewitz, J
King, LR
Ross, TM
Golding, H
ContributionContributors NameEmailPitt UsernameORCID
Centers: Other Centers, Institutes, Offices, or Units > Center for Vaccine Research
Date: 13 August 2010
Date Type: Publication
Journal or Publication Title: PLoS ONE
Volume: 5
Number: 7
DOI or Unique Handle: 10.1371/journal.pone.0011548
Refereed: Yes
MeSH Headings: Animals; Chromatography, Gel; Circular Dichroism; Escherichia coli--genetics; Escherichia coli--metabolism; Ferrets--immunology; Ferrets--virology; Hemagglutinin Glycoproteins, Influenza Virus--chemistry; Hemagglutinin Glycoproteins, Influenza Virus--genetics; Hemagglutinin Glycoproteins, Influenza Virus--immunology; Influenza A Virus, H1N1 Subtype--immunology; Influenza Vaccines--genetics; Influenza Vaccines--immunology; Orthomyxoviridae Infections--immunology; Protein Folding; Surface Plasmon Resonance
Other ID: NLM PMC2902520
PubMed Central ID: PMC2902520
PubMed ID: 20634959
Date Deposited: 03 Aug 2012 21:02
Last Modified: 13 Oct 2017 22:58


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item